A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)
Clinical trial NCT03374241 · COMPLETED
Trial details
- NCT number
- NCT03374241
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-04
- Primary completion
- 2018-09-14
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.